Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniela Montoya Urrego"'
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Introduction Staphylococcus aureus is a successful pathogen in hospital and community. Hemodialysis patients have high colonization rates. Interactions between them and their household contacts, are an opportunity to understand the S. aureus coloniza
Externí odkaz:
https://doaj.org/article/a12f8a0cb36b4005aa0ebc4bc4fb2bcd
Autor:
Johanna Marcela Vanegas Múnera, Ana María Ocampo Ríos, Daniela Montoya Urrego, Judy Natalia Jiménez Quiceno
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 21, Iss 5, Pp 493-499 (2017)
Introduction: Treatment of multidrug-resistant Gram-positive infections caused by Staphylococcus aureus remains as a clinical challenge due to emergence of new resistance mechanisms. Tedizolid is a next-generation oxazolidinone, recently approved for
Externí odkaz:
https://doaj.org/article/5a9a1492189c424f82fc54dcf17c8be0
Autor:
Daniela Montoya-Urrego, Juan José Velasco-Castaño, Juan C Quintero Velez, J Natalia Jiménez Quiceno
Publikováno v:
Infection and Drug Resistance.
Daniela Montoya-Urrego,1 Juan José Velasco-Castaño,1 Juan C Quintero Velez,1â 3 J Natalia Jiménez Quiceno1 1Grupo de Investigación en MicrobiologÃa Básica y Aplicada (MICROBA), Escuela de MicrobiologÃa, Universidad de Antioq
Publikováno v:
Epidemiology and health. 44
Objectives: Increase in colonization by beta-lactam-resistant Gram-negative bacilli (BR-GNB) represent a risk for infections and bacterial resistance spread, not only in hospitals but community. Hemodialysis patients and their household contacts tran
Autor:
J. Natalia Jiménez, Julián Builes, Lorena Salazar-Ospina, Gustavo Roncancio, Daniela Montoya-Urrego, Johanna M. Vanegas
Publikováno v:
Journal of Medical Microbiology. 69:1132-1144
Introduction. While colonization by Staphylococcus aureus in haemodialysis patients has been assessed, knowledge about colonization by beta-lactam-resistant Gram-negative bacilli is still limited. Aim. To describe clinical and molecular characteristi
Autor:
Daniela Montoya Urrego, Judy Natalia Jiménez Quiceno, Johanna Marcela Vanegas Múnera, Ana M. Ocampo de Los Ríos
Publikováno v:
Brazilian Journal of Infectious Diseases, Volume: 21, Issue: 5, Pages: 493-499, Published: OCT 2017
Repositorio UdeA
Universidad de Antioquia
instacron:Universidad de Antioquia
Brazilian Journal of Infectious Diseases, Vol 21, Iss 5, Pp 493-499 (2017)
Brazilian Journal of Infectious Diseases v.21 n.5 2017
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
Repositorio UdeA
Universidad de Antioquia
instacron:Universidad de Antioquia
Brazilian Journal of Infectious Diseases, Vol 21, Iss 5, Pp 493-499 (2017)
Brazilian Journal of Infectious Diseases v.21 n.5 2017
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
Introduction: Treatment of multidrug-resistant Gram-positive infections caused by Staphylococcus aureus remains as a clinical challenge due to emergence of new resistance mechanisms. Tedizolid is a next-generation oxazolidinone, recently approved for